Neuspera Medical, Inc.
San Jose, US · Delaware corporation · 8 known investors
Neuspera develops an integrated sacral neuromodulation system for treating urinary urge incontinence, using a smart implanted neurostimulator paired with a wireless external battery. The device is designed for women with overactive bladder symptoms.
Founders & leadership
MM
Milton M. MorrisExecutive Officer, Director
Investors · 8
Cerity Partners VenturesNew York
Foreground CapitalBoston
PortfoliaSan Mateo
Treo Ventures, LlcMinneapolis
Windham Capital PartnersNew York
Windham Venture PartnersNew York · $1M – $5M
Action Potential Venture Capital Ltd.reportedScotts Valleyvia Imran Eba · board
Vertex Ventures HCreportedSingapore · $500K – $10M
Reported raises · per SEC filings
Form D private placements▶$65.7MraisedJun 2021 · 17 investors · Other Health CareRule 506(b)
▶$65.7MraisedJun 2021 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- MUDIT K. JAINDirector
- ADAM FINEDirector
- ALEXANDER YEHExecutive Officer
- MILTON M. MORRISExecutive Officer, Director
- ART TAYLORDirector
- IMRAN EBADirector
- LORI HUDirector
- Offering amount
- $79.6M
- Amount sold
- $65.7M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14MraisedJan 2018 · 10 investors · BiotechnologyRule 506(b)
▶$14MraisedJan 2018 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam FineDirector
- Ching ZhuDirector
- Milton M. MorrisExecutive Officer, Director
- Art TaylorDirector
- Imran EbaDirector
- Alexander YehExecutive Officer
- Offering amount
- $26M
- Amount sold
- $14M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$8.9MraisedJun 2016 · 4 investors · BiotechnologyRule 506(b)
▶$8.9MraisedJun 2016 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Milton M. MorrisExecutive Officer, Director
- Offering amount
- $8.9M
- Amount sold
- $8.9M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Neuspera Medical secures $23m for SNM systemfinance.yahoo.com · 2024
- Neuspera Medical Raises $23M in Series D Financing for Neuromodulation Advancementssiliconvalleyjournals.com · 2024
- Olympus Innovation Venture News: Neuspera Medical Raises $23 Million in Series D Financing | Olympus America | Medicalmedical.olympusamerica.com · 2024
- Neuromod developer Neuspera Medical raises $23M in Series D - MassDevicemassdevice.com · 2024
- Neuspera Medical Raises $23 Million in Series D Financingprnewswire.com · 2024